Iovance Biotherapeutics, Inc. short interest in 2022
In 2022, Iovance Biotherapeutics, Inc.'s disclosed short interest ran from 7.66% of shares outstanding on 14 Jan 2022 to 13.75% on 30 Dec 2022, a change of +6.09 percentage points. The year's high was 13.75% on 30 Dec 2022 and its low 7.16% on 31 Jan 2022, averaging 10.90% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.79 days on 15 Sep 2022. Full history: Iovance Biotherapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 7.66% (14 Jan 2022)
- End of year
- 13.75% (30 Dec 2022)
- Change
- +6.09 pp
- High
- 13.75% (30 Dec 2022)
- Low
- 7.16% (31 Jan 2022)
- Average
- 10.90%
- Highest days to cover
- 9.79 (15 Sep 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 7.66% | 3.93 | |
| 31 Jan 2022 | 7.16% | 5.05 | |
| 15 Feb 2022 | 7.99% | 7.94 | |
| 28 Feb 2022 | 8.74% | 8.01 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 8.72% | 8.21 | |
| 31 Mar 2022 | 8.85% | 5.66 | |
| 14 Apr 2022 | 9.72% | 5.25 | |
| 29 Apr 2022 | 10.06% | 9.19 | |
| 13 May 2022 | 10.94% | 7.57 | 10-Q filed, results (8-K) |
| 31 May 2022 | 11.05% | 2.85 | |
| 15 Jun 2022 | 10.53% | 1.92 | |
| 30 Jun 2022 | 13.71% | 2.95 | |
| 15 Jul 2022 | 12.69% | 6.05 | |
| 29 Jul 2022 | 12.31% | 7.52 | |
| 15 Aug 2022 | 13.15% | 8.60 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 12.45% | 8.55 | |
| 15 Sep 2022 | 12.38% | 9.79 | |
| 30 Sep 2022 | 11.83% | 8.46 | |
| 14 Oct 2022 | 11.51% | 8.03 | |
| 31 Oct 2022 | 10.94% | 9.34 | |
| 15 Nov 2022 | 11.56% | 5.81 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 11.86% | 4.12 | |
| 15 Dec 2022 | 12.09% | 2.47 | |
| 30 Dec 2022 | 13.75% | 5.34 |
See also: Iovance Biotherapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.